arrow
G

Gerd A. Kullak-Ublick

University of Zurich
H指数:79
被引数:2.6万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Comparison of the Real-World Reporting of Symptoms and Well-Being for the HER2-Directed Trastuzumab Biosimilar Ogivri With Registry Data for Herceptin in the Treatment of Breast Cancer: Prospective Observational Study (OGIPRO) of Electronic Patient-Reported Outcomes

HER2-Directed曲妥珠单抗生物仿制药Ogivri的真实世界症状和健康报告与赫赛汀治疗乳腺癌的注册数据的比较: 电子患者报告结果的前瞻性观察研究 (OGIPRO)

2024-04-041
OA
Roadmap to DILI research in Europe. A proposal from COST action ProEuroDILINet
2024-02-013
OAAI
Nomenclature, diagnosis and management of drug-induced autoimmune-like hepatitis (DI-ALH): An expert opinion meeting report

药物诱导的自身免疫性肝炎 (di-alh) 的命名,诊断和管理: 专家意见会议报告

2023-09-0141
OAAI
Patients with naproxen-induced liver injury display T-cell memory responses toward an oxidative (S)-O-Desmethyl Naproxen metabolite but not the acyl glucuronide

萘普生诱导的肝损伤患者对氧化性 (S)-O-去甲基萘普生代谢物表现出T细胞记忆反应,但对酰基葡糖苷酸没有反应

2023-07-295
OA
A new framework for advancing in drug-induced liver injury research. The Prospective European DILI Registry

推进药物性肝损伤研究的新框架。未来的欧洲帝力登记处

2022-08-1538
OAAI